Cite
HARVARD Citation
Faisal Hamdi, A. et al. (2022). Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?. Expert review of anticancer therapy. 22 (12), pp. 1309-1323. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Faisal Hamdi, A. et al. (2022). Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?. Expert review of anticancer therapy. 22 (12), pp. 1309-1323. [Online].